NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models

NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models

NSC243928 induces cell death in triple-negative breast cancer cells in a LY6K-dependent manner. NSC243928 has been reported as an anti-cancer agent in the NCI small molecule library. The molecular mechanism of NSC243928 as an anti-cancer agent in the treatment of tumor growth in the syngeneic mouse...

Full description

Bibliographic Details
Main Authors: Benson Chellakkan Selvanesan, Alvaro de Mingo Pulido, Sheelu Varghese, Deepak Rohila, Daniel Hupalo, Yuriy Gusev, Sara Contente, Matthew D. Wilkerson, Clifton L. Dalgard, Geeta Upadhyay
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Cancers
Subjects:
LY6K
mammary tumor model
NKT cells
B1 cells
myeloid derived suppressor cells
NSC243928
Online Access:https://www.mdpi.com/2072-6694/15/5/1468

Internet

https://www.mdpi.com/2072-6694/15/5/1468

Similar Items